Search Results - "CUTTER, G. R"

The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment by Fischer, J S, Rudick, R A, Cutter, G R, Reingold, S C

“…Clinical outcome assessment in Multiple Sclerosis (MS) is challenging due to the diversity and fluctuating nature of MS symptoms. Traditional clinical scales…”
Get full text

Development of a multiple sclerosis functional composite as a clinical trial outcome measure by Cutter, Gary R., Baier, Monika L., Rudick, Richard A., Cookfair, Diane L., Fischer, Jill S., Petkau, John, Syndulko, Karl, Weinshenker, Brian G., Antel, Jack P., Confavreux, Christian, Ellison, George W., Lublin, Fred, Miller, Aaron E., Rao, Stephen M., Reingold, Stephen, Thompson, Alan, Willoughby, Ernest

“…The primary clinical outcome measure for evaluating multiple sclerosis in clinical trials has been Kurtzke's expanded disability status scale (EDSS). New…”
Get full text

Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity by Mowry, E M, Loguidice, M J, Daniels, A B, Jacobs, D A, Markowitz, C E, Galetta, S L, Nano-Schiavi, M L, Cutter, G R, Maguire, M G, Balcer, L J

“…Objective:To examine the relation between low contrast letter acuity, a new visual function test for multiple sclerosis (MS) trials, and vision targeted health…”
Get full text

Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis by BAIER, M. L, CUTTER, G. R, RUDICK, R. A, MILLER, D, COHEN, J. A, WEINSTOCK-GUTTMAN, B, MASS, M, BALCER, L. J

“…To evaluate concurrent and predictive validity for low-contrast letter acuity (L-CLA) testing as a candidate visual component for the Multiple Sclerosis…”
Get full text

Constraint-Induced Movement therapy can improve hemiparetic progressive multiple sclerosis. Preliminary findings by Mark, VW, Taub, E, Bashir, K, Uswatte, G, Delgado, A, Bowman, MH, Bryson, CC, McKay, S, Cutter, GR

“…Objective To evaluate whether Constraint-Induced Movement therapy (CI therapy) may benefit chronic upper extremity hemiparesis in progressive multiple…”
Get full text

Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite by BALCER, L. J, BAIER, M. L, HEIDENREICH, F. R, JACOBS, D. A, MARKOWITZ, C. E, STUART, W. H, YING, G.-S, GALETTA, S. L, MAGUIRE, M. G, CUTTER, G. R, COHEN, J. A, KOOIJMANS, M. F, SANDROCK, A. W, NANO-SCHIAVI, M. L, PFOHL, D. C, MILLS, M, BOWEN, J, FORD, C

“…Visual dysfunction is one of the most common causes of disability in multiple sclerosis (MS). The Multiple Sclerosis Functional Composite (MSFC), a new…”
Get full text

Genetic Diversity of Plaque Mutans Streptococci with rep-PCR by Cheon, K., Moser, S.A., Whiddon, J., Osgood, R.C., Momeni, S., Ruby, J.D., Cutter, G.R., Allison, D.B., Childers, N.K.

“…Mutans streptococci (MS) are key organisms associated with the etiology of dental caries. Using probabilities that were tested by oversampling, we designed…”
Get full text

Corticospinal Tract Abnormalities Are Associated with Weakness in Multiple Sclerosis by Reich, D.S, Zackowski, K.M, Gordon-Lipkin, E.M, Smith, S.A, Chodkowski, B.A, Cutter, G.R, Calabresi, P.A

“…The association of MR imaging abnormalities with clinical disability in multiple sclerosis (MS) has been disappointing. This association might be improved by…”
Get full text

Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses by Petkau, J, Reingold, SC, Held, U, Cutter, GR, Fleming, TR, Hughes, MD, Miller, DH, McFarland, HF, Wolinsky, JS

“…Background Magnetic resonance imaging (MRI) of lesions in the brain may be the best current candidate for a surrogate biological marker of clinical outcomes in…”
Get full text

Relation of vision to global and regional brain MRI in multiple sclerosis by WU, G. F, SCHWARTZ, E. D, CUTTER, G. R, CALABRESI, P. A, UDUPA, J. K, BALCER, L. J, LEI, T, SOUZA, A, MISHRA, S, JACOBS, D. A, MARKOWITZ, C. E, GALETTA, S. L, NANO-SCHIAVI, M. L, DESIDERIO, L. M

“…To examine the relation between low-contrast letter acuity, an emerging visual outcome for multiple sclerosis (MS) clinical trials, and brain MRI abnormalities…”
Get full text

Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn by Kinsella, John P., Truog, William E., Walsh, William F., Goldberg, Ronald N., Bancalari, Eduardo, Mayock, Dennis E., Redding, Gregory J., deLemos, Robert A., Sardesai, Smeeta, McCurnin, Donald C., Moreland, Susan G., Cutter, Gary R., Abman, Steven H.

“…Background: Although inhaled nitric oxide (iNO) causes selective pulmonary vasodilation and improves oxygenation in newborn infants with persistent pulmonary…”
Get full text

Translation of a Ski School Sun Safety Program to North American Ski and Snowboard Schools by Walkosz, Barbara J., Buller, David B., Andersen, Peter A., Scott, M. D., Liu, X., Cutter, G. R., Dignan, M. B.

“…Health promotion programs that develop and implement strategies to promote sun safety practices to children have the potential to reduce skin cancer occurrence…”
Get full text

Estimating long-term effects of disease-modifying drug therapy in multiple sclerosis patients by Rudick, R A, Cutter, G R, Baier, M, Weinstock-Guttman, B, Mass, M K, Fisher, E, Miller, D M, Sandrock, A W

“…Two methods were used to estimate the long-term impact of disease-modifying drug therapy (DMDT) in patients with relapsing multiple sclerosis (MS) who…”
Get full text

Comparison of full-field digital mammography with screen-film mammography for cancer detection: results of 4,945 paired examinations by Lewin, J M, Hendrick, R E, D'Orsi, C J, Isaacs, P K, Moss, L J, Karellas, A, Sisney, G A, Kuni, C C, Cutter, G R

“…To prospectively compare full-field digital mammography (FFDM) with screen-film mammography (SFM) for cancer detection in a screening population. At two…”
Get more information

Modeling lesion counts in multiple sclerosis when patients have been selected for baseline activity by Morgan, CJ, Aban, IB, Katholi, CR, Cutter, GR

“…The number of new gadolinium-enhancing lesions discovered via magnetic resonance imaging is a well-established outcome for multiple sclerosis studies,…”
Get full text

The Importance of Physical and Biogenic Structure to Juvenile Fishes on the Shallow Inner Continental Shelf by Diaz, R. J., Cutter, G. R., Able, K. W.

“…Fish-habitat relationships on the shallow inner continental shelf were quantified with video sled and metered beam trawl on Fenwick and Weaver shoals offshore…”
Get full text

Predictive value of p16 or Rb inactivation in a model of naturally occurring canine non-Hodgkin's lymphoma by Modiano, J F, Breen, M, Valli, V E O, Wojcieszyn, J W, Cutter, G R

Get full text

Intrarater and interrater reliability of the MS functional composite outcome measure by COHEN, J. A, FISCHER, J. S, BOLIBRUSH, D. M, JAK, A. J, KNIKER, J. E, MERTZ, L. A, SKARAMAGAS, T. T, CUTTER, G. R

“…To assess practice effects, and intrarater and interrater reliability of the MS functional composite (MSFC) outcome measure. To address the poor reliability…”
Get full text

Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial by Kinsella, John P, Walsh, William F, Bose, Carl L, Gerstmann, Dale R, Labella, JJ, Sardesai, Smeeta, Walsh-Sukys, Michele C, McCaffrey, Martin J, Cornfield, David N, Bhutani, Vinod K, Cutter, Gary R, Baier, Monika, Abman, Steven H

“…Inhaled nitric oxide improves oxygenation and lessens the need for extracorporeal-membrane oxygenation in full-term neonates with hypoxaemic respiratory…”
Get full text

Proof of concept studies for tissue-protective agents in multiple sclerosis by Mehta, LR, Schwid, SR, Arnold, DL, Cutter, GR, Aradhye, S, Balcer, LJ, Calabresi, PA, Cohen, JA, Cole, PE, Glanzman, R, Goelz, S, Inglese, M, Kapoor, R, Kappos, L, Kreitman, R, Lublin, FD, Mann, A, Marrie, RA, O'Looney, P, Polman, CH, Ravina, BM, Reingold, SC, Richert, JR, Sandrock, AW, Waubant, E

“…Background There is considerable interest in tissue-protective treatments for multiple sclerosis (MS). Methods and Objectives We convened a group of MS…”
Get full text